- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03348995
The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration
August 17, 2023 updated by: Miach Orthopaedics
A Prospective Cohort Clinical Trial Evaluating Age as a Risk Factor for Poor Outcomes of Bridge-Enhanced ACL Restoration (BEAR)
Bridge-Enhanced ACL Restoration (BEAR) is a new procedure being developed to treat patients with ACL injuries.
In the BEAR procedure, an implant is placed between the torn ends of the ACL and the patient's own blood is added to the implant to stimulate ligament healing.
We propose the current study to determine if older patients do better than younger patients (or vice versa) with this procedure.
This is a cohort study designed to determine if age is a risk factor for a worse outcome after a bridge-enhanced ACL repair (BEAR) as defined by an 11.5 point difference on the IKDC Subjective or Objective Knee Evaluation score at two years after surgery.
Additional objectives are to determine the effect of age on safety outcomes including infection, graft rejection, and need for further surgical procedures.
Study Overview
Status
Active, not recruiting
Intervention / Treatment
Detailed Description
The BEAR III study is a cohort study designed to determine if age is a risk factor for a worse outcome after a bridge-enhanced ACL restoration (BEAR) as defined by an 11.5 point difference on the IKDC Subjective or Objective Knee Evaluation score at two years after surgery.
Additional objectives are to determine the effect of age on safety outcomes including infection, graft rejection, and need for further surgical procedures.
Study Type
Interventional
Enrollment (Estimated)
250
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Rita A Paparazzo, BS/MBA
- Phone Number: 107 +18005906995
- Email: clinicaltrials@miachortho.com
Study Contact Backup
- Name: Kim Mooney, BS
- Phone Number: +18005906995
- Email: clinicaltrials@miachortho.com
Study Locations
-
-
California
-
San Diego, California, United States, 92121
- Scripps Health
-
-
Florida
-
Tampa, Florida, United States, 33637
- Florida Orthopedic Institute
-
-
Georgia
-
Atlanta, Georgia, United States, 30329
- Emory University School of Medicine
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70121
- Ochsner Sports Medicine Institute
-
-
Maryland
-
Lutherville, Maryland, United States, 21093
- MedStar Health Surgery Center of Timonium
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Boston Children's Hospital
-
-
New Jersey
-
Marlton, New Jersey, United States, 08053
- Virtua Health
-
-
Rhode Island
-
Providence, Rhode Island, United States, 02903
- Cynthia Chrostek
-
-
South Dakota
-
Sioux Falls, South Dakota, United States, 57105
- Orthopedic Institute of Sioux Falls
-
-
Texas
-
Dallas, Texas, United States, 75390
- UT Southwestern
-
-
Virginia
-
Fairfax, Virginia, United States, 22031
- Inova Sports Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 78 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria: ACL tear, within 50 days of injury, at least 5% of the ACL attached to the tibia.
-
Exclusion Criteria: Prior surgery on the affected knee, history of knee infection, use of tobacco, use of corticosteroid, chemotherapy, allergy to bovine products or gelatin, history of anaphylaxis, BMI over 35, moderate osteoarthritis.
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Bridge-Enhanced ACL Restoration (BEAR)
The BEAR technique involves surgically placing an absorbable implant (the BEAR Implant) between the torn ends of the ACL, providing a scaffold for the ligament ends to grow into
|
In the BEAR Procedure, surgery is performed to sew the ACL back together and a scaffold is placed between the torn ends at the time of repair.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
International Knee Documentation Committee Subjective Score (IKDC) (Survey)
Time Frame: Time points up to two years
|
This is a survey patients complete about how their knee is feeling and functioning.
Range is 0 to 100, with 100 indicating no problems and 0 indicating extreme problems.
|
Time points up to two years
|
International Knee Documentation Committee Objective Score (IKDC) (Physical Exam)
Time Frame: Time points up to two years.
|
This is an examination performed of the knee.
Scores are one of four measures: A (Normal), B (Nearly Normal), C (Abnormal) and D (Severely Abnormal).
A is the best outcome and D is the worst.
|
Time points up to two years.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Knee Injury and Osteoarthritis Score (KOOS) questionnaire
Time Frame: Time points up to two years
|
This is a survey with 5 subscales (Pain, Symptoms, Function in Daily Living, Function in Sport and Recreation, and Knee Related Quality of Life).
The range of each subscale is 0 to 100, with 100 indicating no problems and 0 indicating extreme problems.
The subscales are reported individually and not combined.
|
Time points up to two years
|
Repair Failure
Time Frame: Two years
|
The number of times patients develop recurrent knee stability and require another ACL surgery.
|
Two years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 17, 2018
Primary Completion (Estimated)
April 17, 2024
Study Completion (Estimated)
April 17, 2034
Study Registration Dates
First Submitted
November 17, 2017
First Submitted That Met QC Criteria
November 17, 2017
First Posted (Actual)
November 21, 2017
Study Record Updates
Last Update Posted (Actual)
August 21, 2023
Last Update Submitted That Met QC Criteria
August 17, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BEAR III Trial
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anterior Cruciate Ligament Rupture
-
Bezirkskrankenhaus SchwazNot yet recruitingAnterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Reconstruction | Anterior Cruciate Ligament InjuryAustria
-
University of Colorado, DenverChildren's Hospital ColoradoRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearUnited States
-
Karolinska InstitutetRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearSweden
-
Rush University Medical CenterEnrolling by invitationAnterior Cruciate Ligament Rupture | Anterior Cruciate Ligament InjuryUnited States
-
Bahçeşehir UniversityIstanbul University - Cerrahpasa (IUC)CompletedAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearTurkey
-
University of BathVersus ArthritisRecruitingPost-traumatic Osteoarthritis | Anterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Tear | Anterior Cruciate Ligament ReconstructionUnited Kingdom
-
Artromedical Konrad Malinowski ClinicRecruitingAnalysis of Radiological Features of Lateral Femoral Impaction Fracture / Lateral Femoral Notch SignAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearPoland
-
Artromedical Konrad Malinowski ClinicRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearPoland
-
Liverpool University Hospitals NHS Foundation TrustRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearUnited Kingdom
-
Johanna M. HochCompletedAnterior Cruciate Ligament Rupture | Anterior Cruciate Ligament InjuryUnited States
Clinical Trials on Bridge-Enhanced ACL Restoration (BEAR)
-
The Cleveland ClinicNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsRecruitingAnterior Cruciate Ligament TearUnited States
-
Columbia UniversityNational Institute on Drug Abuse (NIDA)CompletedSubstance Abuse, Intravenous | Human Immunodeficiency VirusUnited States, Kazakhstan
-
Massachusetts General HospitalCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host Disease | Myelodysplastic/Myeloproliferative NeoplasmsUnited States